These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21563687)

  • 1. Substitute technology for reference substances in the analysis of impurities in cefonicid for injection with HPLC using a diode array detector.
    Li W
    J AOAC Int; 2011; 94(2):531-6. PubMed ID: 21563687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectral correlation of high-performance liquid chromatography-diode array detection data from two independent chromatographic runs peak tracking in pharmaceutical impurity profiling.
    Li W; Hu CQ
    J Chromatogr A; 2008 May; 1190(1-2):141-9. PubMed ID: 18374928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A digitized impurity database analysis method for determining the impurity profiles of gatifloxacin in bulk materials and injections.
    Dousheng Z; Yan C; Yaping L; Shangchen Y; Changqin H
    Pharmazie; 2012 Oct; 67(10):827-33. PubMed ID: 23136715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative impurity profiling by principal component analysis of high-performance liquid chromatography-diode array detection data.
    Wiberg K
    J Chromatogr A; 2006 Mar; 1108(1):50-67. PubMed ID: 16430906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of impurity peaks in the HPLC chromatogram by LC-MS and two-dimensional chromatographic correlation spectroscopy].
    Chen ZZ; Zhang DS; Wang N; Feng F; Hu CQ
    Yao Xue Xue Bao; 2012 Apr; 47(4):492-7. PubMed ID: 22799032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of related substances in rifampicin by HPLC-DAD spectroscopy correlation].
    Li W; Hu CQ; Jin SH
    Yao Xue Xue Bao; 2007 Dec; 42(12):1292-7. PubMed ID: 18338643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis.
    Broecker S; Pragst F; Bakdash A; Herre S; Tsokos M
    Forensic Sci Int; 2011 Oct; 212(1-3):215-26. PubMed ID: 21764531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active drug substance impurity profiling part I. LC/UV diode array spectral matching.
    Nicolas EC; Scholz TH
    J Pharm Biomed Anal; 1998 Jan; 16(5):813-24. PubMed ID: 9535194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradient HPLC-diode array detector stability-indicating determination of lidocaine hydrochloride and cetylpyridinium chloride in two combined oral gel dosage forms.
    Belal TS; Shaalan RA; Haggag RS
    J AOAC Int; 2011; 94(2):503-12. PubMed ID: 21563684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gradient HPLC-DAD stability indicating determination of miconazole nitrate and lidocaine hydrochloride in their combined oral gel dosage form.
    Belal TS; Haggag RS
    J Chromatogr Sci; 2012 May; 50(5):401-9. PubMed ID: 22407005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis combined with chromatographic fingerprint for comprehensive evaluation of Xiaoer Chaigui Tuire granules by HPLC-DAD.
    Liu HM; Nie L
    J Chromatogr Sci; 2015; 53(5):749-56. PubMed ID: 25234384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
    Wu CS; Tong YF; Wang PY; Wang DM; Wu S; Zhang JL
    Rapid Commun Mass Spectrom; 2013 May; 27(9):971-8. PubMed ID: 23592199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic characterization and quantitative determination of atorvastatin calcium impurities by novel HPLC method.
    Gupta LK
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():495-501. PubMed ID: 22842103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Qualitative identification of impurities and principal component quantitative analysis of zearalanone on purity certified reference material].
    Feng M; Liu S; Gao Y; Zhou S; Guo Z; Li X; Zhang Q
    Se Pu; 2019 Aug; 37(8):911-917. PubMed ID: 31642263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Separation and identification of chlorogenic acid and related impurities by high performance liquid chromatography-tandem mass spectrometry].
    Tian C; Xu X; Liao L; Zhang J; Liu J; Zhou S
    Se Pu; 2007 Jul; 25(4):496-500. PubMed ID: 17970105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurity profiling of micronomicin sulfate injection by liquid chromatography-ion trap mass spectrometry.
    Yuan YZ; Zhao X; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Mar; 75():94-104. PubMed ID: 23261805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.